Holly L Cranmer

8PUBLICATIONS
17CO-AUTHORS
Cross-sectional analysisPredictive and prognostic markersRehabilitationMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 01, 2025
Caring for and Caring about in Economic Evaluation: Modelling the Family and Caregiving Effects.

Becky Pennington, Sarah Davis, Holly Cranmer

|Feb 28, 2023
An Investigation into the Relationship Between Choice of Model Structure and How to Adjust for Subsequent Therapies Using a Case Study in Oncology.

Holly L Cranmer, Gemma E Shields, Ash Bullement

|Feb 27, 2023
Cost-effectiveness of home-based cardiac rehabilitation: a systematic review.

Gemma E Shields, Aleix Rowlandson, Garima Dalal

|May 24, 2022
Indirect comparisons of brigatinib and alectinib for front-line <i>ALK</i>-positive non-small-cell lung cancer.

Karen L Reckamp, Huamao M Lin, Holly Cranmer

|Dec 09, 2021
Cost-effectiveness of brentuximab vedotin for the treatment of cutaneous T-cell lymphoma.

Tanja Podkonjak, Holly Cranmer, Julia Scarisbrick

Pageof 2